摘要
In recent years, the clinical efficacy of traditional Chinese medicine (TCM) in treating malignant tumor has attracted more and more attention of oncologic societies at home and abroad. What is the superiority of TCM in treating malignant tumor? And what is the bottleneck of clinical trial of TCM? These are the major research topic to be recognized by TCM society since many years ago.
